Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study

Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study

Abstract Background Phase 3 studies suggest that induction chemotherapy (ICT) of cisplatin and 5-fluorouracil plus docetaxel (TPF) is effective but toxic for patients with squamous-cell carcinoma of the head and neck (SCCHN). Dose-dense chemotherapy may yield favorable outcomes compared with standar...

Full description

Bibliographic Details
Main Authors: Ching-Yun Hsieh, Ming-Yuh Lein, Shih-Neng Yang, Yao-Ching Wang, Yin-Jun Lin, Chen-Yuan Lin, Chun-Hung Hua, Ming-Hsul Tsai, Ching-Chan Lin
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cancer
Subjects:
Head and neck cancer
Docetaxel
Cisplatin
Fluorouracil
Dose-dense chemotherapy
Induction chemotherapy
Online Access:http://link.springer.com/article/10.1186/s12885-020-07347-6

Internet

http://link.springer.com/article/10.1186/s12885-020-07347-6

Similar Items